Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

[Cytotoxic mechanism and antineoplastic action of etoposide].

Dołega A.

Postepy Hig Med Dosw. 1998;52(1):67-87. Review. Polish.

PMID:
9608232
2.

Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.

Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.

Clin Cancer Res. 2000 Apr;6(4):1488-97.

3.

ICRF-193 modifies etoposide-induced apoptosis in thymocytes.

Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z.

Acta Med Okayama. 1995 Dec;49(6):281-6.

PMID:
8770236
4.
5.

BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II.

Treszezamsky AD, Kachnic LA, Feng Z, Zhang J, Tokadjian C, Powell SN.

Cancer Res. 2007 Aug 1;67(15):7078-81.

6.

MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.

Moneypenny CG, Shao J, Song Y, Gallagher EP.

Carcinogenesis. 2006 Apr;27(4):874-81. Epub 2005 Dec 24.

PMID:
16377807
7.

Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).

Chen Y, Su YH, Wang CH, Wu JM, Chen JC, Tseng SH.

Anticancer Res. 2005 Nov-Dec;25(6B):4203-8.

8.

Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives.

Humeniuk R, Kaczmarek L, Peczyńska-Czoch W, Marcinkowska E.

Oncol Res. 2003;13(5):269-77.

PMID:
12688678
9.

DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.

Byl JA, Cline SD, Utsugi T, Kobunai T, Yamada Y, Osheroff N.

Biochemistry. 2001 Jan 23;40(3):712-8.

PMID:
11170388
10.

Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.

Jarvis WD, Johnson CR, Fornari FA, Park JS, Dent P, Grant S.

J Pharmacol Exp Ther. 1999 Sep;290(3):1384-92.

11.

Cellular response to etoposide treatment.

Montecucco A, Biamonti G.

Cancer Lett. 2007 Jul 8;252(1):9-18. Epub 2006 Dec 12. Review.

PMID:
17166655
12.

The role of telomeres in Etoposide induced tumor cell death.

Jeyapalan J, Leake A, Ahmed S, Saretzki G, Tilby M, von Zglinicki T.

Cell Cycle. 2004 Sep;3(9):1169-76. Epub 2004 Sep 13.

PMID:
15326395
13.

Unique biochemical, cytotoxic, and antitumor activity of camptothecin and 4beta-amino-4'-O-demethylepipodophyllotoxin conjugates.

Chang JY, Guo X, Chen HX, Jiang Z, Fu Q, Wang HK, Bastow KF, Zhu XK, Guan J, Lee KH, Cheng YC.

Biochem Pharmacol. 2000 Mar 1;59(5):497-508.

PMID:
10660116
14.

Complex response of breast epithelial cell lines to topoisomerase inhibitors.

Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR.

Anticancer Res. 1998 Jul-Aug;18(4C):2919-32.

PMID:
9713486
15.

Concentration-dependent variable effects of etoposide on the cell cycle of CML cells.

Fukumi S, Horiguchi-Yamada J, Iwase S, Ohno T, Yamada H.

Anticancer Res. 2000 Sep-Oct;20(5A):3105-10.

PMID:
11062729
17.

Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.

Godard T, Deslandes E, Sichel F, Poul JM, Gauduchon P.

Mutat Res. 2002 Sep 26;520(1-2):47-56.

PMID:
12297143
18.

Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.

Facompré M, Wattez N, Kluza J, Lansiaux A, Bailly C.

Mol Cell Biol Res Commun. 2000 Jul;4(1):37-42.

PMID:
11152626
19.

Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.

Chiu CC, Li CH, Ung MW, Fuh TS, Chen WL, Fang K.

Cancer Lett. 2005 Jun 8;223(2):249-58. Epub 2004 Dec 15.

PMID:
15896459
20.

Supplemental Content

Support Center